ROXANN RICHARDSON: Open Payments
NPI 1902428915 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 43 payments from 11 companies in 2025. Trend: 2023 $283 · 2024 $790 · 2025 $1,361
Food & beverage: $1,284Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $368 |
| UCB, Inc. | 5 | $238 |
| Janssen Biotech, Inc. | 4 | $200 |
| GENZYME CORPORATION | 2 | $162 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| Lilly USA, LLC | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Bimzelx, RINVOQ, TREMFYA, SKYRIZI, SILIQ, DUPIXENT, COSENTYX, JUBLIA.
Industry payments across NV — which companies pay providers there.
